Elliot Howard Schuman, MD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 825 Century Medical Dr, Suite A, Titusville, FL 32796 Phone: 321-269-0747 Fax: 321-269-8485 |
Antonio Caos, MD Internal Medicine - Gastroenterology Medicare: Medicare Enrolled Practice Location: 407 S Washington Ave Ste 1, Titusville, FL 32796 Phone: 321-385-0884 Fax: 321-385-9578 |
Dr. William Rylander, M.D. Internal Medicine - Gastroenterology Medicare: Accepting Medicare Assignments Practice Location: 407 S Washington Ave, Suite 1, Titusville, FL 32796 Phone: 321-385-0884 Fax: 321-385-9578 |
Dr. Jian-jun Chen, MD, PHD Internal Medicine - Gastroenterology Medicare: Not Enrolled in Medicare Practice Location: 407 S Washington Ave, Suite 1, Titusville, FL 32796 Phone: 321-385-0884 Fax: 321-385-9578 |
News Archive
Researchers from Imperial College London provide a mathematical model to help understand how SARS-CoV-2, the causative pathogen of (COVID-19), spread across England in the first two waves of the epidemic, and the effect of various interventions by the government.
The COO of the Patient Centered Outcomes Research Institute offered insights into what appears to be a busy agenda, according to two subscription publications.
Scientists who search for new pesticides for use in humanity's battle of the bugs and other threats to the food supply have been learning lessons from Mother Nature, according to a new analysis. It concludes that more than two out of every three new pesticide active ingredients approved in recent years had roots in natural substances produced in plants or animals. The article appears in ACS' Journal of Natural Products.
Elsevier, a world-leading provider of scientific, technical and medical information products and services, and the International Society of Nephrology, the global medical society devoted to advancing kidney care worldwide, announced today that Elsevier will publish ISN's flagship journals, Kidney International and Kidney International Supplements, as of January 1, 2016.
Debiopharm Group (Debiopharm), a Swiss-based global biopharmaceutical group of companies with a focus on the development of prescription drugs that target unmet medical needs, and Ipsen (Euronext: FR0010259150; IPN), an innovation-driven global specialty pharmaceutical Group, announced that the 6-month sustained-release formulation of Decapeptyl®1 (triptorelin embonate2 22.5 mg) successfully completed its European decentralised registration procedure involving nine countries: Germany (reference member state), France, Austria, Finland, Norway, Belgium, Denmark, Spain and The Netherlands.
› Verified 3 days ago